Correlation Between West Pharmaceutical and MultiPlan

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both West Pharmaceutical and MultiPlan at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining West Pharmaceutical and MultiPlan into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between West Pharmaceutical Services and MultiPlan, you can compare the effects of market volatilities on West Pharmaceutical and MultiPlan and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in West Pharmaceutical with a short position of MultiPlan. Check out your portfolio center. Please also check ongoing floating volatility patterns of West Pharmaceutical and MultiPlan.

Diversification Opportunities for West Pharmaceutical and MultiPlan

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between West and MultiPlan is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding West Pharmaceutical Services and MultiPlan in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MultiPlan and West Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on West Pharmaceutical Services are associated (or correlated) with MultiPlan. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MultiPlan has no effect on the direction of West Pharmaceutical i.e., West Pharmaceutical and MultiPlan go up and down completely randomly.

Pair Corralation between West Pharmaceutical and MultiPlan

Considering the 90-day investment horizon West Pharmaceutical Services is expected to generate 0.43 times more return on investment than MultiPlan. However, West Pharmaceutical Services is 2.33 times less risky than MultiPlan. It trades about 0.09 of its potential returns per unit of risk. MultiPlan is currently generating about -0.05 per unit of risk. If you would invest  29,023  in West Pharmaceutical Services on September 5, 2024 and sell it today you would earn a total of  3,085  from holding West Pharmaceutical Services or generate 10.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

West Pharmaceutical Services  vs.  MultiPlan

 Performance 
       Timeline  
West Pharmaceutical 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in West Pharmaceutical Services are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, West Pharmaceutical may actually be approaching a critical reversion point that can send shares even higher in January 2025.
MultiPlan 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days MultiPlan has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

West Pharmaceutical and MultiPlan Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with West Pharmaceutical and MultiPlan

The main advantage of trading using opposite West Pharmaceutical and MultiPlan positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if West Pharmaceutical position performs unexpectedly, MultiPlan can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MultiPlan will offset losses from the drop in MultiPlan's long position.
The idea behind West Pharmaceutical Services and MultiPlan pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Transaction History
View history of all your transactions and understand their impact on performance
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA